Document is current
Any future updates will be listed below
-
Authors
Peck, Stephanie Knatz
Brewerton, Timothy D.
Fisher, Hannah
Trim, Julie
Shao, Samantha
Modlin, Nadav Liam
Kim, Jessie
Finn, Daphna M.
Kaye, Walter H.
-
Funding
Funding for this research was provided by:
Compass Pathways (n/a)
Compass Pathways (n/a)
Compass Pathways (n/a)
- License Information
-
More Information
Article History
Received: 1 January 2025
Accepted: 24 April 2025
First Online: 26 May 2025
Declarations
:
: All participants provided written informed consent to participate. All study and assessments received ethical approvals. The study was approved by the Federal Drug Administration (FDA), the Regulatory Approval Committee of California (RAP-C), and the UC San Diego’s Institutional Review Board (site specific approvals). All participants provided written informed consent to the study team personnel at the start of the in-person screening visit, review of the manuscript in its entirety, and written permission to publish the case reports and information
: Stephanie Knatz Peck is a senior clinical consultant for Compass Pathways, the study funder. Compass Pathways played no role in data collection, analysis, manuscript preparation or ideas expressed in this manuscript.
